These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8442107)

  • 1. Natural killer defined haplotypes are associated with particular ancestral haplotypes: implications for bone marrow transplantation.
    Christiansen FT; Witt CS; Ciccone E; Pende D; Viale O; Dawkins RL; Moretta L
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1259-60. PubMed ID: 8442107
    [No Abstract]   [Full Text] [Related]  

  • 2. Ancestral haplotypes predict EC-1 alleles.
    Christiansen FT; Witt CS; Ciccone E; Pende D; Viale O; Dawkins RL; Moretta L
    Transplant Proc; 1992 Oct; 24(5):2333-4. PubMed ID: 1413084
    [No Abstract]   [Full Text] [Related]  

  • 3. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells, HLA class I molecules, and marrow transplantation.
    Valiante NM; Parham P
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):229-35. PubMed ID: 9450917
    [No Abstract]   [Full Text] [Related]  

  • 5. Allorecognition by murine natural killer cells: studies with bone marrow transplants and lysis of T lymphoblasts.
    Liu J; Yu YY; Lindahl KF; Kumar V; Bennett M
    Chem Immunol; 1996; 64():164-80. PubMed ID: 8942079
    [No Abstract]   [Full Text] [Related]  

  • 6. Receptors that turn on and turn off natural killer cells.
    Chong AS
    J Heart Lung Transplant; 1996 Jul; 15(7):675-83. PubMed ID: 8820783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of natural killer cells and classical (RT1.A) vs nonclassical (RT1.C) class I molecules in acute bone marrow allograft rejection in lethally irradiated rats.
    Engh E; Benestad HB; Rolstad B
    Transplant Proc; 1996 Dec; 28(6):3265-6. PubMed ID: 8962267
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell crossmatch: functional analysis of inhibitory killer immunoglobulin-like receptors and their HLA ligands.
    Han M; Fallena M; Guo Y; Stastny P
    Hum Immunol; 2007 Jun; 68(6):507-13. PubMed ID: 17509450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes.
    Christiansen FT; Witt CS; Ciccone E; Townend D; Pende D; Viale D; Abraham LJ; Dawkins RL; Moretta L
    J Exp Med; 1993 Sep; 178(3):1033-9. PubMed ID: 8350045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and functional characterization of peripheral blood and bone marrow natural killer cells prior to autologous transplantation.
    Arbour S; Toupin S; Bélanger R; Gyger M; Hallé JP; Perreault C; Roy DC
    Bone Marrow Transplant; 1996 Mar; 17(3):315-22. PubMed ID: 8704680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of anergic histoincompatible bone marrow cells.
    Gallardo D; Grañena A; García-López J
    N Engl J Med; 1999 Sep; 341(14):1082. PubMed ID: 10507929
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural killer cells in peripheral blood after autologous bone marrow transplantation: a combined phenotypic and functional study.
    Jorgensen H; Hokland P; Jensen T; Basse P; Hokland M
    Nat Immun; 1995; 14(3):164-72. PubMed ID: 8832900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation: analysis of the surface expression and function of activating NK receptors.
    Vitale C; Chiossone L; Morreale G; Lanino E; Cottalasso F; Moretti S; Dini G; Moretta L; Mingari MC
    Mol Immunol; 2005 Feb; 42(4):405-11. PubMed ID: 15607791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of leukemic relapse soon after bone marrow transplantation.
    Tratkiewicz JA; Szer J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2648-50. PubMed ID: 3274575
    [No Abstract]   [Full Text] [Related]  

  • 17. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
    Ruggeri L; Capanni M; Urbani E; Perruccio K; Shlomchik WD; Tosti A; Posati S; Rogaia D; Frassoni F; Aversa F; Martelli MF; Velardi A
    Science; 2002 Mar; 295(5562):2097-100. PubMed ID: 11896281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunobiology of natural killer cells and bone marrow allograft rejection.
    Barao I; Murphy WJ
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):727-41. PubMed ID: 14677112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation.
    Vitale C; Chiossone L; Morreale G; Lanino E; Cottalasso F; Moretti S; Dini G; Moretta L; Mingari MC
    Eur J Immunol; 2004 Feb; 34(2):455-60. PubMed ID: 14768050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.